Lightspeed led Warp Sciences' Series A, backing AI-driven robotic labs that automate drug discovery chemistry. The BIOSECURE Act and lab automation advances create demand for a domestic alternative to offshore providers, while Warp's robotics capture failed experiments to train better AI models.
Read the full post on Lightspeed Venture Partners Blog ↗
Topics: Biotech & Life Sciences · AI Infrastructure · Robotics
Published by Lightspeed Venture Partners Blog · their site ↗
SandHill indexes 800+ venture capital blogs and newsletters and sends the best of them every Sunday. Browse the sources · browse by topic · read the blog.
Suggest a blog or newsletter for the SandHill index. We track the RSS feed and feature the best pieces in the weekly digest.
The latest theses & analyses from 800+ venture investors, curated into one email. Join 5,000+ investors, founders and LPs.